![A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population | Journal of Managed Care & Specialty Pharmacy A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population | Journal of Managed Care & Specialty Pharmacy](https://www.jmcp.org/cms/10.18553/jmcp.2020.26.5.639/asset/images/fig1.jpg)
A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population | Journal of Managed Care & Specialty Pharmacy
![Anticoagulation During Pregnancy: Evolving Strategies With a Focus on Mechanical Valves - ScienceDirect Anticoagulation During Pregnancy: Evolving Strategies With a Focus on Mechanical Valves - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S073510971635032X-gr1.jpg)
Anticoagulation During Pregnancy: Evolving Strategies With a Focus on Mechanical Valves - ScienceDirect
![Apixaban therapy in a pregnant woman with heparin-induced thrombocytopenia and venous thromboembolic events caused by congenital antithrombin deficiency: A case report - ScienceDirect Apixaban therapy in a pregnant woman with heparin-induced thrombocytopenia and venous thromboembolic events caused by congenital antithrombin deficiency: A case report - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2214911220300308-gr1.jpg)
Apixaban therapy in a pregnant woman with heparin-induced thrombocytopenia and venous thromboembolic events caused by congenital antithrombin deficiency: A case report - ScienceDirect
![Cells | Free Full-Text | Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications Cells | Free Full-Text | Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications](https://www.mdpi.com/cells/cells-11-03214/article_deploy/html/images/cells-11-03214-g001.png)
Cells | Free Full-Text | Anticoagulants: A Short History, Their Mechanism of Action, Pharmacology, and Indications
![JCM | Free Full-Text | Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study JCM | Free Full-Text | Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study](https://pub.mdpi-res.com/jcm/jcm-09-01633/article_deploy/html/images/jcm-09-01633-g001-550.jpg?1592746947)
JCM | Free Full-Text | Effectiveness and Safety of Oral Anticoagulants among NVAF Patients with Obesity: Insights from the ARISTOPHANES Study
![Patient selection criteria. AF: atrial fibrillation; NOAC: non-vitamin... | Download Scientific Diagram Patient selection criteria. AF: atrial fibrillation; NOAC: non-vitamin... | Download Scientific Diagram](https://www.researchgate.net/publication/328682815/figure/fig1/AS:688473484845062@1541156278696/Patient-selection-criteria-AF-atrial-fibrillation-NOAC-non-vitamin-K-antagonist-oral.jpg)
Patient selection criteria. AF: atrial fibrillation; NOAC: non-vitamin... | Download Scientific Diagram
![Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity | Advances in Therapy Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity | Advances in Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs12325-022-02387-9/MediaObjects/12325_2022_2387_Fig1_HTML.png)
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity | Advances in Therapy
![Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study - Research and Practice in Thrombosis and Haemostasis Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study - Research and Practice in Thrombosis and Haemostasis](https://www.rpthjournal.org/cms/asset/a0d88149-d1f9-4cc1-a7cf-26b25d12a319/rth212221-fig-0001-m.jpg)
Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study - Research and Practice in Thrombosis and Haemostasis
![Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack | Stroke Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack | Stroke](https://www.ahajournals.org/cms/asset/b0f2e3cc-4fa3-41cb-97ff-8b6147aa59d7/2142fig01.jpg)
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack | Stroke
![Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey - Onur Aslan, Y. T. Yaylali, S. Yildirim, M. Yurtdas, H. Senol, M. Ugur-Yildiz, M. Ozdemir, 2016 Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey - Onur Aslan, Y. T. Yaylali, S. Yildirim, M. Yurtdas, H. Senol, M. Ugur-Yildiz, M. Ozdemir, 2016](https://journals.sagepub.com/cms/10.1177/1076029614546327/asset/images/large/10.1177_1076029614546327-fig1.jpeg)
Dabigatran Versus Warfarin in Atrial Fibrillation: Multicenter Experience in Turkey - Onur Aslan, Y. T. Yaylali, S. Yildirim, M. Yurtdas, H. Senol, M. Ugur-Yildiz, M. Ozdemir, 2016
![These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA® (dabigatran etexilate) oral pellets Initial U.S. These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA® (dabigatran etexilate) oral pellets Initial U.S.](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=pradaxa-21.jpg&id=749356)
These highlights do not include all the information needed to use PRADAXA Oral Pellets safely and effectively. See full prescribing information for PRADAXA Oral Pellets. PRADAXA® (dabigatran etexilate) oral pellets Initial U.S.
![Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus - ScienceDirect Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0025619619306123-gr1.jpg)
Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus - ScienceDirect
Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with
![Venous thromboembolism, chronic liver disease and anticoagulant choice: effectiveness and safety of direct oral anticoagulants versus warfarin - Research and Practice in Thrombosis and Haemostasis Venous thromboembolism, chronic liver disease and anticoagulant choice: effectiveness and safety of direct oral anticoagulants versus warfarin - Research and Practice in Thrombosis and Haemostasis](https://www.rpthjournal.org/cms/attachment/99e2789e-f970-4ccc-9a1b-3652da4ff0c5/gr1_lrg.jpg)